Home
/
NextCure, Inc.
/
Financials
/
Quarterly
NextCure, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NextCure, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2020
$22.38M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$22.38M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$22.38M
May 6, 2021
Q3
2020
Sep 30, 2019
$1.58M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$1.40M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$1.36M
May 7, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.62M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($26.81M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($26.81M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($10.98M)
Aug 7, 2025
Q3
2025
Mar 31, 2025
($10.98M)
Nov 5, 2025
Q1
2025
Mar 31, 2025
($10.98M)
May 1, 2025
Q3
2025
Sep 30, 2024
($11.54M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($15.40M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($15.40M)
Nov 5, 2025
Q1
2025
Mar 31, 2024
($17.11M)
May 1, 2025
Q2
2025
Mar 31, 2024
($17.11M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($17.11M)
Nov 5, 2025
Q3
2024
Sep 30, 2023
($14.30M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($17.86M)
Aug 1, 2024
Q3
2024
Jun 30, 2023
($17.86M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($16.10M)
May 2, 2024
Q2
2024
Mar 31, 2023
($16.10M)
Aug 1, 2024
Q3
2024
Mar 31, 2023
($16.10M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($18.91M)
Nov 2, 2023
Q3
2023
Jun 30, 2022
($17.92M)
Nov 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.95M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($27.29M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($11.62M)
May 1, 2025
Q3
2025
Sep 30, 2024
($12.50M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($16.49M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($18.30M)
May 1, 2025
Q3
2024
Sep 30, 2023
($15.62M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($19.16M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
($17.07M)
May 2, 2024
Q3
2023
Sep 30, 2022
($19.24M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($18.13M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($20.77M)
May 4, 2023
Q3
2022
Sep 30, 2021
($18.51M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($17.95M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($17.23M)
May 5, 2022
Q3
2021
Sep 30, 2020
($17.40M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($15.80M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
$8.21M
May 6, 2021
Q3
2020
Sep 30, 2019
($9.70M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($8.96M)
Aug 6, 2020